News
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is ...
Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says ...
Novo Nordisk reduced its starter dose prices through telehealth platforms to encourage patients to wean themselves off compounded copycats.
3don MSN
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...
15h
Dagens.com on MSNThis New Pill Could Replace Wegovy and Ozempic — No Injections RequiredA revolution in weight loss treatment may soon be on the way — and it doesn’t involve a needle. Eli Lilly, the pharmaceutical giant behind some of today’s most powerful diabetes and obesity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results